The 2023 GOLD Report: Updated Guidelines for Inhaled Pharmacological Therapy in Patients with Stable COPD
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
The 2023 GOLD Report: Updated Guidelines for Inhaled Pharmacological Therapy in Patients with Stable COPD ; volume:9 ; number:3 ; day:20 ; month:7 ; year:2023 ; pages:345-357 ; date:9.2023
Pulmonary therapy ; 9, Heft 3 (20.7.2023), 345-357, 9.2023
- Urheber
-
Terry, Paul D.
Dhand, Rajiv
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s41030-023-00233-z
- URN
-
urn:nbn:de:101:1-2023110609375222282247
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Terry, Paul D.
- Dhand, Rajiv
- SpringerLink (Online service)
Ähnliche Objekte (12)
Admission prevention in COPD: non-pharmacological management
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Updated guidelines for gene nomenclature in wheat
Updated clinical guidelines experience major reporting limitations
Updated recommendations: an assessment of NICE clinical guidelines
Inhaled β-agonist does not modify sympathetic activity in patients with COPD
A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD
Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)
Updated guidelines for chronic active Epstein–Barr virus disease
Correction to: Updated clinical guidelines experience major reporting limitations
An updated review of cucurbitacins and their biological and pharmacological activities
Admission prevention in COPD: non-pharmacological management
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Updated guidelines for gene nomenclature in wheat
Updated clinical guidelines experience major reporting limitations
Updated recommendations: an assessment of NICE clinical guidelines
Inhaled β-agonist does not modify sympathetic activity in patients with COPD
A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD
Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)
Updated guidelines for chronic active Epstein–Barr virus disease
Correction to: Updated clinical guidelines experience major reporting limitations
An updated review of cucurbitacins and their biological and pharmacological activities
Admission prevention in COPD: non-pharmacological management
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Updated guidelines for gene nomenclature in wheat
Updated clinical guidelines experience major reporting limitations
Updated recommendations: an assessment of NICE clinical guidelines
Inhaled β-agonist does not modify sympathetic activity in patients with COPD
A descriptive cohort study of withdrawal from inhaled corticosteroids in COPD patients
Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD
Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)
Updated guidelines for chronic active Epstein–Barr virus disease
Correction to: Updated clinical guidelines experience major reporting limitations